Interpat Innovation Seminar, Brazilia

“Healthcare Innovation as a tool for societal progress and economic growth”

Interpat, Universidad El Bosque, Universidad San Francisco de Quito and Foundation Galaxea proudly present the 2023 edition of the Innovation Seminar to be held on 28 and 29 of November 2023 in the capital of Brazil, the city of Brasilia/Federal District. This year the theme of the event will be “Health care innovation as a tool for societal progress and economic growth”.

Intellectual property in catalyzing healthcare innovation. By exploring the intricate relationship between these realms, our objective is to foster groundbreaking discussions that raise healthcare standards and effectively address societal health dilemmas, particularly in Latin America. To delve deeper, we’re assembling industry and IP luminaries from the region to share insights and chart future strategies. This event promises 2 days of enlightening expert panels, dynamic interaction, and valuable networking. Esteemed judges, officials, academics and entrepreneurs across Latin America, leading in these fields, will grace the seminar. Simultaneous translation (English, Portuguese, Spanish) will be provided.

Updated Brazil IP Study now available to view here

Interpat Winter General Assembly Meeting, Copenhagen, 13-15 November 2023

Our Winter 2023 General Assembly meeting will be held in Copenhagen, Denmark from Monday 13 November-Wednesday 15 November 2023. (Interpat members and affiliates only)

Launch of the Interpat South Korea IP Study

Value of IP for health and growth : The economic benefits of strengthening the innovation environment in South Korea.

We are excited to launch a new report on IP in South Korea .

The study will be presented at Interpat’s Summer General Assembly in Seoul  on Wednesday 14 June 2023 and will form the basis of discussion for a panel of experts moderated by Andrew Jenner

(more…)

Interpat Summer General Assembly, Seoul, 12-14 June 2023

Our Summer 2023 General Assembly will be held in Seoul, South Korea from Monday 12 June-Wednesday 14 June 2023. (Interpat members and affiliates only)

AMIIF-FIFARMA Innovation Week, 28 March-30 March 2023 (Day 2 & 3)

Day 2 & 3: Virtual

Innovation Week Agenda: Agenda SI23 ENGLISH

Andrew Jenner, Interpat DG, will be contributing to the discussion on Innovation Ecosystems (Panel 8) on 30 March.

Register in the link below

Panel 4: Overcoming challenges in cancer care: an interdisciplinary approach

Panel 5: Innovations in care and delivery of treatments: expanding access

Panel 6: Technology as a key factor to reduce health inequities

Panel 7: Facing the challenges of mental health and dementia: a multidisciplinary perspective

Panel 8: Innovation ecosystems: factor for social development in health

Panel 9: Advanced therapies: changing the course in disease care

Panel 10: Maximizing the impact on health with a value-based approach

Panel 11: Clinical research: trends in the innovation industry

AMIIF-FIFARMA Innovation Week, 28 March-30 March 2023 (Day 1)

Day 1: On-site live event 

To commemorate their anniversary, AMIIF will be holding the traditional innovation week. This year it is organised in conjunction with the Latin American Federation of the Pharmaceutical Industry (FIFARMA). There will be participation from several international speakers from WIPO, IFPMA and other organisations.

Andrew Jenner, DG of INTERPAT will participate in the discussions on the Innovation Ecosystems (Day 3, Panel 8)

Innovation Week Agenda:  Agenda SI23 ENGLISH

Day 1

Panel 1: Ethics and social value in the pharma industry and the health sector

Panel 2: Experiences in care for noncommunicable diseases with a gender approach

Panel 3: Advances and Challenges of patient associations

Launching the IP PACT: Our approach to Intellectual Property with patient and societal benefit at its core

Medical innovations driven by the biopharmaceutical industry have played a fundamental role in helping people live longer, healthier lives. As the global population’s health needs become increasingly complex, it is ever more essential that we research and develop life-saving medicines and vaccines to meet these challenges. Intellectual Property (IP) has been central to great scientific advances and for ensuring that patients have access to this innovation. IP helps foster long term investment to benefit patients – today and tomorrow.